Kangmei Pharma | 600518 - Loan Capital

Stock Price
1.78
Daily Change
-0.01 -0.56%
Monthly
-5.32%
Yearly
-11.00%
Q2 Forecast
1.71

Kangmei Pharma reported CNY78.45M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Genomma Lab Internacional MXN 4.8B 180.57M Dec/2025
Hypermarcas BRL 8.11B 551.86M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Jiangsu Hengrui CNY 43.31M 8.11M Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Moderna USD 610M 584M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Sh Fosun Pharma CNY 15.39B 1.34B Dec/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.48B 7M Dec/2025
Wuxi Apptec CNY 2.27B 475.26M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025